Alkylating Agents Market to Witness an Outstanding Growth by 2025
The organization also projected that the number of cancer cases could reach 22 million by 2032. Lung, liver, stomach, colorectal, and breast are among the leading cause of cancer deaths. The high mortality rate and wide prevalence of cancer have driven scientists to engage in the discovery of better treatment options of the disease. Alkylating agents were among the earliest classes of drugs available for treating cancer. These are the first nonhormonal drugs successfully used in the cancer treatment. Traditionally,...
View full press release